Risk stratification of hepatocellular carcinoma after hepatitis C virus eradication in patients with compensated advanced chronic liver disease in Japan
- 11 March 2022
- journal article
- letter
- Published by Elsevier in Journal of Hepatology
- Vol. 77 (2) , 569-571
Abstract
No abstract availableKeywords
Funding Information
- Japan Agency for Medical Research and Development
- Japan Society for the Promotion of Science
- Government of Japan Ministry of Health Labour and Welfare
This publication has 8 references indexed in Scilit:
- HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver diseaseJournal of Hepatology, 2022
- Impact of Obesity and Heavy Alcohol Consumption on Hepatocellular Carcinoma Development after HCV Eradication with AntiviralsLiver Cancer, 2021
- Non-invasive prediction of liver-related events in patients with HCV-associated compensated advanced chronic liver disease after oral antiviralsJournal of Hepatology, 2020
- Liver stiffness measurements in chronic hepatitis C: Treatment evaluation and risk assessmentJournal of Gastroenterology and Hepatology, 2018
- Association Between Sustained Virological Response and All-Cause Mortality Among Patients With Chronic Hepatitis C and Advanced Hepatic FibrosisJAMA, 2012
- Effect of aging on risk for hepatocellular carcinoma in chronic hepatitis C virus infection†Hepatology, 2010
- Prospective risk assessment for hepatocellular carcinoma development in patients with chronic hepatitis C by transient elastography†Hepatology, 2009
- Hepatic venous pressure gradient predicts development of hepatocellular carcinoma independently of severity of cirrhosisJournal of Hepatology, 2009